MedTrace Logo

Could Single-anastomosis Gastric Bypass Be a Curative Treatment for Type II Diabetes?

NCT03412253 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2018-01-26

No results posted yet for this study

Summary

Single- Anastomosis gastric bypass (SAGB) is a potentially curative line of treatment for type II diabetes mellitus (T2DM) patients with BMI 25-30 kg/m2. Accordingly, SAGB could be integrated into T2DM treatment algorithm

Conditions

  • Metabolic Surgery

Interventions

PROCEDURE

Single-Anastomosis Gastric Bypass surgery (SAGB).

We checked the effect of SAGB on patients suffered from T2DM with BMI 25-30

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-01
Primary Completion
2016-03-31
Completion
2018-02-04

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03412253 on ClinicalTrials.gov